LMN-201

· Lumen Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LMN-201, covering 2025-03-18 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: LMN-201 for Prevention of C. Difficile Infection Recurrence [Phase 2, Phase 3]